Acuta Capital Partners as of Dec. 31, 2019
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 36 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 15.6 | $63M | 608k | 103.36 | |
| SPDR S&P Biotech (XBI) | 11.8 | $48M | 500k | 95.11 | |
| Arrowhead Pharmaceuticals (ARWR) | 7.0 | $28M | 443k | 63.43 | |
| Kadmon Hldgs | 6.8 | $27M | 6.0M | 4.53 | |
| Intra Cellular Therapies (ITCI) | 5.8 | $24M | 687k | 34.31 | |
| Aurinia Pharmaceuticals (AUPH) | 5.3 | $21M | 1.1M | 20.26 | |
| Iovance Biotherapeutics (IOVA) | 4.5 | $18M | 657k | 27.68 | |
| Adverum Biotechnologies | 4.1 | $16M | 1.4M | 11.52 | |
| Arvinas Ord (ARVN) | 3.6 | $15M | 356k | 41.09 | |
| Flamel Technologies Sa (AVDL) | 3.0 | $12M | 1.6M | 7.55 | |
| Xenon Pharmaceuticals (XENE) | 3.0 | $12M | 918k | 13.11 | |
| Karyopharm Therapeutics (KPTI) | 2.8 | $11M | 590k | 19.17 | |
| BioCryst Pharmaceuticals (BCRX) | 2.4 | $9.7M | 2.8M | 3.45 | |
| Constellation Pharmceticls I | 2.3 | $9.3M | 198k | 47.11 | |
| Dicerna Pharmaceuticals | 2.1 | $8.5M | 388k | 22.03 | |
| Milestone Pharmaceuticals (MIST) | 2.0 | $8.1M | 509k | 16.01 | |
| Iveric Bio | 1.9 | $7.8M | 910k | 8.58 | |
| Reata Pharmaceuticals Inc Cl A | 1.9 | $7.8M | 38k | 204.42 | |
| Bellus Health | 1.5 | $6.2M | 810k | 7.60 | |
| Apellis Pharmaceuticals (APLS) | 1.4 | $5.7M | 188k | 30.62 | |
| Selecta Biosciences (RNAC) | 1.3 | $5.3M | 2.4M | 2.26 | |
| Neoleukin Therapeutics | 1.1 | $4.6M | 373k | 12.32 | |
| Karuna Therapeutics Ord | 1.0 | $4.2M | 56k | 75.34 | |
| Insmed (INSM) | 1.0 | $4.0M | 169k | 23.88 | |
| Applied Therapeutics (APLT) | 1.0 | $4.0M | 148k | 27.28 | |
| Kura Oncology (KURA) | 0.8 | $3.3M | 240k | 13.75 | |
| Immunomedics | 0.8 | $3.2M | 150k | 21.16 | |
| Zymeworks | 0.8 | $3.2M | 71k | 45.46 | |
| Ascendis Pharma A S (ASND) | 0.8 | $3.1M | 23k | 139.11 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $1.9M | 108k | 17.81 | |
| Medicines Company | 0.5 | $1.8M | 22k | 84.93 | |
| Uniqure Nv (QURE) | 0.4 | $1.8M | 25k | 71.68 | |
| Acasti Pharma | 0.4 | $1.5M | 620k | 2.45 | |
| Chemocentryx | 0.3 | $1.4M | 35k | 39.54 | |
| Zafgen | 0.3 | $1.1M | 1.0M | 1.11 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $428k | 40k | 10.70 |
